Price target upside
Evogene Ltd. - Ordinary Shares Price Target Upside or Downside
EVGN price target upside based on the current price and analyst average.
Direct answer
Evogene Ltd. - Ordinary Shares's analyst target implies +240%.
The average target is $2.15 compared with a recorded current price of $0.63.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 11, 2026.
Get free Evogene Ltd. - Ordinary Shares email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.63
- Average price target
- $2.15
- High price target
- $2.15
- Low price target
- $2.15
- Target upside
- +240%
- Consensus rating
- none
- Analysts
- 1
- Evidence date
- August 11, 2026
- Valid through
- August 18, 2026